The researchers used machine learning to build predictive models for individuals' future risks of nine common diseases, based on their genetic information and the biomarkers that they measured.
One-third of Type 2 diabetic adults may have undiagnosed cardiovascular disease. In persons with Type 2 diabetes compared to those without Type 2 diabetes, elevated levels of two protein biomarkers that signify heart damage were linked to undiagnosed or symptomless cardiovascular disease.
Medical professionals are getting closer to developing a risk biomarker that will let them know which of their paediatric stem cell transplant patients are most likely to have sinusoidal obstruction syndrome (SOS), a potentially lethal side effect.
While some individuals are able to recover from the consequences of SARS-CoV-2 infection, others have continued to endure COVID-19 aftereffects for a very long time. The inability to exercise as much is one of these persistent COVID symptoms. But there are still unanswered issues about the r
Doctors are one step closer to establishing a risk biomarker that will warn them as to which of their paediatric stem cell transplant patients are likely to encounter sinusoidal obstruction syndrome (SOS), a potentially fatal side effect.
Researchers have recorded pain-related data from inside the brains of people suffering from chronic pain issues caused by stroke or amputation (phantom limb pain) for the first time. Understanding how pain is represented by brain activity and how to modify that activity to treat chronic pain
Calprotectin levels in stool samples can be used to diagnose or monitor common inflammatory conditions such as ulcerative colitis and Crohn's disease, while serum levels of calprotectin can be used to monitor the inflammation state in rheumatoid arthritis. Calprotectin concentrations in pati
Irregularities in the body's genetic code for protein production have been linked to malignant tumours. However, most genetic material contains components whose purpose is unknown.
Organoids produced from patients with head and neck cancer (HNC) were used to create a biobank by researchers from the Organoid group (Hubrecht Institute) and UMC Utrecht. They used this biobank to validate known HNC indicators, and they discovered that therapy responses in organoids matched